Latest Production News

Adelong Gold Limited has formally declared a deadlock in its joint venture with Great Divide Mining, prompting a dispute resolution process as both parties contest the status of their collaboration.

Rokeby Resources has secured $1.7 million through an oversubscribed share placement to fund expanded drilling at its promising Hurricane gold and antimony project in Queensland.

Vital Metals Limited has voluntarily suspended trading of its shares pending a key announcement on a capital raise, following an ASX price and volume query.

Schaffer Corporation reported a 16% rise in underlying net profit for FY25, driven by strong Automotive Leather and Delta divisions, while maintaining its dividend and appointing a new CEO to steer future growth.

LTR Pharma’s intranasal ED treatment SPONTAN achieves peak effect up to five times faster than oral tablets, according to new peer-reviewed clinical data published in a leading European journal.

Ovanti Limited has secured a strategic three-year partnership with Shift4 Payments to launch its innovative Buy Now Pay Later services across over 100,000 US merchants, leveraging AI-driven credit models and stablecoin-backed funding.

Lindian Resources has approved the Final Investment Decision for its Kangankunde Rare Earths Project, securing full funding and a strategic partnership with Iluka Resources. The company is raising A$91.5 million via institutional placement to advance development and expansion plans.

Lindian Resources has raised A$91.5 million through a strong institutional placement, enabling the final investment decision for the Kangankunde Rare Earths Project’s Stage 1 development with production targeted for late 2026.

Lycopodium Limited delivered robust FY25 financial results, hitting the top end of guidance with $339.6 million revenue and $42.2 million net profit. The company’s strategic SAXUM acquisition broadens its footprint in the Americas, positioning it well for growth in critical minerals and clean energy sectors.

TG Metals reports encouraging assay results from historical stockpiles and secures approvals for in-pit drilling at its Van Uden Gold Project, aiming to unlock near-term cash flow opportunities.

Pharmx Technologies reported a 13% increase in FY25 revenues to $7.53 million, driven by strong growth across its Gateway and Marketplace platforms. The company maintained positive EBITDA and a solid cash position despite legal expenses, setting the stage for an ambitious FY26 growth strategy.

Pharmx Technologies has reported a 13% revenue increase to $7.5 million for FY25, driven by expanded partnerships and platform innovations, despite a dip in EBITDA due to heavy investment.